Logo

Luminex: Dijuana Lewis

Sep 09, 2019

Luminex has elected Dijuana Lewis as an independent director to its board of directors, to the board's compensation and nominating committee, and to its corporate governance committee.

In a filing with the US Securities and Exchange Commission, Luminex reported that Lewis has served on various nonprofit and advisory boards and has consulted on healthcare related matters since her retirement from Aetna in April 2016.

She served Aetna as executive vice president, consumer products and enterprise marketing from October 2013 to April 2016. Prior to that, she served as senior vice president, health and wellness for Walmart Stores from March 2011 to October 2013. Further, Lewis previously served in a number of executive level positions of increasing responsibility with Anthem/Wellpoint from August 1994 to January 2011, including as the executive vice president and chief executive officer of its comprehensive health solutions division from October 2007 to January 2011.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.